Intravitreal steroids in the management of macular oedema

Plasma concentrations were obtained from 21 patients with macular edema due to branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO), and 21 patients with diabetic macular edema (DME) prior to dosing and at 4 to 5 additional post-dose timepoints on Days 1, 7, 21, 30, 45, 60, and 90 following the administration of the first intravitreal implant containing mg dexamethasone. In RVO and DME patients, the majority of plasma dexamethasone concentrations were below the lower limit of quantitation (LLOQ = 50 pg/mL). Plasma dexamethasone concentrations from 12% of samples were above the LLOQ, ranging from 52 pg/mL to 102 pg/mL. Plasma dexamethasone concentration did not appear to be related to age, body weight, or sex of patients.

Disclaimer: The information listed on this website is given in goodfaith . Ipoh Eye Specialist Centre shall not be responsible for any errors or omissions contained within this website, and reserves the right to make changes . All Ipoh Eye Specialist Centre and third party information is provided on an "as is"basis. Ipoh Eye Specialist Centre shall not be liable for indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to any of the information contained in this website, whether such damages arise in contract, negligence, under statute, tort, in equity, at law or otherwise.

Intravitreal steroids in the management of macular oedema

intravitreal steroids in the management of macular oedema

Media:

intravitreal steroids in the management of macular oedemaintravitreal steroids in the management of macular oedemaintravitreal steroids in the management of macular oedemaintravitreal steroids in the management of macular oedemaintravitreal steroids in the management of macular oedema

http://buy-steroids.org